ABPMP Philadelphia Chapter
How a process orientation contributes to greater success with AI.
Andrew Spanyi
​
Oct 1, 2025 (12:00 pm EST)
Organizations often rush to implement artificial intelligence without laying the groundwork for sustainable value creation. A process-oriented approach provides the foundation needed for AI initiatives to succeed. This talk explores how adopting a process mindset—focusing on how work is done, how value flows, and how decisions are made—enables more success with AI.
Process orientation clarifies objectives, exposes inefficiencies, and ensures high-quality data pipelines, all of which are critical for training and deploying reliable AI models. It also enables cross-functional collaboration and accountability, reducing resistance to change and aligning AI projects with business goals. By treating AI as a capability that improves end-to-end process performance—not as a standalone solution—organizations are more likely to scale impact and avoid isolated, short-lived pilots.
Real-world examples from financial services and healthcare illustrate how process thinking enhances the strategic use of AI. Attendees will leave with practical insights for embedding AI within a process excellence framework.
Andrew Spanyi is the Founder and President of Spanyi International Inc. He is also the Editor at Cognitive World. Andrew’s work on process management and operational leadership is internationally recognized. He is the author of three books, over 100 articles, and has delivered speeches and workshops in countries all around the world. His 2003 book "BPM is a Team Sport - Play it to Win" was widely acknowledged as laying the foundation for the importance of customer focus and collaboration in deploying BPM. Andrew founded Spanyi International Inc. in 1991.
He is a BPM fellow with the Association of BPM Professionals. Andrew previously taught process management at Babson College and was a member of the Babson Institute of Process Management. Earlier, Andrew was a Managing Partner of The Rummler-Brache Group (Canada).
Andrew has worked on over 170 major projects and has served clients in a broad range of industries, including aerospace, banking, government, insurance, chemical, pharmaceutical, and telecommunications. His current work is focused on redesigning the oncology clinical trial process with a focus on patient experience, process innovation, and digital technologies.